DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia

Show full item record



Permalink

http://hdl.handle.net/10138/233337

Citation

Clinical Epigenetics. 2018 Mar 05;10(1):31

Title: DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Author: Borssén, Magnus; Nordlund, Jessica; Haider, Zahra; Landfors, Mattias; Larsson, Pär; Kanerva, Jukka; Schmiegelow, Kjeld; Flaegstad, Trond; Jónsson, Ólafur G; Frost, Britt-Marie; Palle, Josefine; Forestier, Erik; Heyman, Mats; Hultdin, Magnus; Lönnerholm, Gudmar; Degerman, Sofie
Publisher: BioMed Central
Date: 2018-03-05
URI: http://hdl.handle.net/10138/233337
Abstract: Abstract Background Few biological markers are associated with survival after relapse of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). In pediatric T-cell ALL, we have identified promoter-associated methylation alterations that correlate with prognosis. Here, the prognostic relevance of CpG island methylation phenotype (CIMP) classification was investigated in pediatric BCP-ALL patients. Methods Six hundred and one BCP-ALL samples from Nordic pediatric patients (age 1–18) were CIMP classified at initial diagnosis and analyzed in relation to clinical data. Results Among the 137 patients that later relapsed, patients with a CIMP− profile (n = 42) at initial diagnosis had an inferior overall survival (pOS5years 33%) compared to CIMP+ patients (n = 95, pOS5years 65%) (p = 0.001), which remained significant in a Cox proportional hazards model including previously defined risk factors. Conclusion CIMP classification is a strong candidate for improved risk stratification of relapsed BCP-ALL.
Subject: DNA methylation
BCP-ALL
Prognosis
CIMP
Relapse
Risk stratification
Rights: The Author(s).


Files in this item

Total number of downloads: Loading...

Files Size Format View
13148_2018_Article_466.pdf 648.4Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record